Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Key Ratios

Price & Volume
Recent Price$1.59
52 Week High$2.43
52 Week Low$0.31
Average Volume (30 days)6.13M
Share Related Items
Market Cap$138.87M
Shares Outstanding87.34M
Dividend Information
Yield %--
Annual Dividend--
Payout Ratio-200.0%
Financial Strength
Quick Ratio (MRQ)3.2
Current Ratio (MRQ)4.3
LT Debt/Capital (MRQ)18%
Total Debt/Equity (MRQ)44%
Valuation Ratios
Price/Earnings (TTM)(3.70)
Price/Sales (TTM)--
Price/Book (MRQ)9.87
Price/Cash Flow (TTM)--
Per Share Data
Earnings (TTM)($0.44)
Sales (TTM)$0.00
Book Value (MRQ)$0.17
Cash Flow (TTM)($0.32)
Cash (MRQ)$0.29
Management Effectiveness
Return on Equity (TTM)-179.4%
Return on Assets (TTM)-93.8%
Return on Investment (TTM)-108.8%
Gross Margin (TTM)--
EBIT Margin (TTM)-11,269.0%
Profit Margin (TTM)--